George A. Digenis, Ph.D. - University of Kentucky - College of ...

"An evaluation of GI transit and bioavailability of ranitidine from a sustained release
formualtion in fasted and fed healthy adult volunteers", Glaxo Canada, Continuation service
contract for $14,238 for a total of $101,725.
"Development and testing of guar gum formulations in beagle dogs", Cibus Pharmaceutical,
$74,031, 3-1-94/02-28-97; $16,773 through April 28, 1997.
"Ranitidine/guar gum formulations. II. A pharmacokinetic and scintigraphic evaluation in
healthy human volunteers", Cibus Pharmaceutical, Continuation service contract for $5,088
for a total of $47,839, 1/14/94.
"Bioavailability of amoxicillin from stressed and non-stressed hard gelatin capsules and in
vivo assessment of capsule rupture by gamma scintigraphy", Warner-Lambert/Capsugel,
$48,913, 9-13-94/9-12-96.
"Evaluation of gastrointestinal drug absorption in mini-pigs via aromatic azo cross-linked
polymer coated formulation and gamma scintigraphy", ONO Pharmaceutical, Inc., $3,723,
12-01-94/11-30-96.
"A pharmacokinetic and scintigraphic evaluation of ranitidne guar gum formulations in
healthy human volunteers", Cibus Pharmaceutical Inc., $37,226, 2-23-95/03-11-96.
"In vivo evaluation of a multi-layered oral tablet by gamma scintigraphy using single or dual
labeling methods and neutron activated Samarium-153 and Ytterbium-175", JAGO/P.G.,
$43,716, 4-1-95/3-31-96.
"In vitro diffusion of iodine from Duraprep", 3M Company, $9,765, 07-01-95/12-31-95.
"An evaluation of nasal spray deposition and clearance", Bausch & Lomb, $12,512., 08-28-
95/12-31-95.
"F-19 (NMR) analysis of trifluoroacetic acid (TFA) in human urine samples", 3M Company
(Harrison), $10,458, 9-1-95/12-31-95.
"External Scintigraphy and Pharmacokinetic Studies on Oral Formulations of Drugs which
Show Discontinuous Absorption in the Gastrointestinal Tract", Recordati, $26,057, 8-31-
96/9-25-96.
"In vivo scintigraphic evaluation of a pulsatile delivery system", TSRL, $25,865, 8-21-95/08-
20-96.
"An evaluation of nasal spray deposition and clearance, Part II: Glunisolide Nasal Solutions",
Bausch & Lomb, $9,362, 10-18-95/12-31-95.
"In Vivo Evaluation of the absorption and GI transit of BMS-180048 in the fed and fasted
subjects using gamma scintigraphy", Bristol-Meyers, $42,172, 11-20-95/02-29-96.
"An evaluation of nasal spray deposition and clearance part III: Desmopressin acetate nasal
solutions", Bausch & Lomb, $9,362, 12-01-95/01-31-96.
"Gamma Scintigraphic Determination in Beagles of In Vivo disintegration and dispersal of
oral dosage form containing bile salt sequestering agents, DuPont Merck, $40,320, 2-1-
96/1-31-97.
"Pilot Synthesis of 2'-MPA", Baker Norton Pharmaceuticals, $55,440, 3-1/96/2-28-97.
"A Bioavailability Study of Leuprolide Acetate Directly Relased in the Ileum and Colon of
Healthy, Young Subjects by a Remote Controlled Delivery Device", Cibus, $9,450, 07-20-
96/07-19-97.
"Site Absorption studies of SC-66110 in Beagles Using a Remote Controlled Capsule and
Gamma Scintigraphy", G.D. Searle & Co, $26,430, 12-15-96/12-14-97.
50